Ascelia has now submitted Orviglance to the FDA. The next step is to start the initial filing review...
Taaleri hosted its CMD today in Helsinki. The CMD offered a detailed description of Taaleri's strate...
Enrad AB:s nettoomsättning om 15,2 MSEK under kv2 2025 understeg vår prognos om 16,2 MSEK med ca 6%.
Återhämtningen i Q2 gick snabbare än väntat och nu väntar vi på de fulla effekterna av beredskapslok...
Redeye updates its estimates and fair value range following Dala Energi’s Q2 report that was release...
Redeye provides an update following Mindark’s Q2 2025 report.
NoHo Partners announced today that it has acquired the majority stake of 75% in the smoothie and jui...
Redeye is positive about Kardium’s FDA approval for the Globe system, which allows the commercial ph...
VBG Group redovisade ett fortsatt svagt andra kvartal med lägre omsättning och marginaler, men vi se...
Vi bedömer att Case Group fortsätter att växa det förvaltade kapitalet, men tillväxttakten har redan...
Following a rights issue that was 61% oversubscribed, BeammWave has completed a subsequent directed ...
ChargePanel tecknade i juni avtal med fordonsleasingsbolaget Arval, som är ett dotterbolag till stor...
* Q2 below ABGSCe; revenues in line, but costs higher * Talisker adds NOK ~0.
Redeye return with an updated view following Nekkar’s Q2 figures that posted mixed figures during a ...
Redeye is only making very small adjustments to our forecasts on the back of Systemair’s Q1 report.
